Obermatt
See Similar Stocks →

Forte Biosciences

NAQ:FBRX · US34962G2084
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings43
Price/Book85
Dividend Yield—
Revenue Growth—
Profit Growth76
Capital Growth18
TSR 52w50
Leverage24
Liquidity83
Refinancing33
Combined—
Analyst Opinions100
Pro Holdings49
Opinion Changes50
Market Pulse5

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Websitefortebiorx.com/home/default.aspx
ISINUS34962G2084
Last UpdateApr 2, 2026
Index & Theme
DermatologyEndocrinologyDiabetesImmunologyChronic DiseasesBiotechnologyLife SciencePharmaceutical

Description

Forte Biosciences, Inc., together with its subsidiaries, operates as a clinical-stage biopharmaceutical company. The company’s lead product candidate is FB102. FB102 is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentia…

Similar Stocks

The companies this stock is ranked against.

Compare Forte Biosciences with its peers
Immunic
NAQ:IMUX
38
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Sana Biotechnology
NSQ:SANA
63
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Arcutis Biotherapeutics
NSQ:ARQT
54
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Celcuity
NAQ:CELC
96
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Xbiotech
NSQ:XBIT
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zenas Biopharma
NSQ:ZBIO
42
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →